DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9

Lignende værker

• Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
  af: van de Ven, Rieneke, et al.
  Udgivet: (2018)
• Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs
  af: Yi, Yongxiang, et al.
  Udgivet: (2012)
• Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
  af: Hilton, Traci, et al.
  Udgivet: (2014)
• Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
  af: Sanborn, Rachel, et al.
  Udgivet: (2015)
• A case of mistaken identity: HSPs are no DAMPs but DAMPERs
  af: van Eden, Willem, et al.
  Udgivet: (2011)